Guide to Targeted Therapies: EGFR mutations in NSCLC

Beschreibung

Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide.
Guide to Targeted Therapies: EGFR Mutations in NSCLC is a speedy and up-to-date review, which discusses EGFR mutations, testing methods and technology, current and emerging therapies, and resources that clinicians can provide to their patients. Busy healthcare professionals who want a quick review of EGFR gene mutations as well as a summary of current therapies will benefit from this succinct guide.
A concise, practical handbook on EGFR mutations in NSCLC that provides oncologists and other healthcare providers with an up-to-date review of the background and advances in the field Reviews the current treatment recommendations for EGFR mutations in NSCLC and emerging treatment options based on recent clinical trials Easily accessible text, tables, and images reviews the critical clinical trials, giving readers a fast synopsis of key studies and available treatment options Includes supplementary material: sn.pub/extras

Autor*in

Federico Cappuzzo

Themen in »Guide to Targeted Therapies: EGFR mutations in NSCLC«

Epidermal growth factor receptor Non-small cell lung cancer Pulmonology pharmacotherapy

Stimmen zu »Guide to Targeted Therapies: EGFR mutations in NSCLC«

Details

Link teilen